UNSPSC 51192009: Halofenate

This classification denotes a uricosuric agent and anti-lipidemic agent with the molecular formula C19H17ClF3NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K9TZK4MNO6, chemically known as (p-chlorophenyl)((alpha,alpha,alpha-trifluoro-m-tolyl)oxy)acetic acid ester with n-(2-hydroxyethyl)acetamide but generally known as halofenate, which bears US NIH Compound Identifier 33584. European Medicines Agency schedules Halofenate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07999MIG.

UNSPSC 51192009 Halofenate is a Commodity code that shows no relevant recent state and local procurement activity. The three opportunities posted since April 2026 under this code — a District Attorney's Office dog procurement from Washington County, Oregon; athletic training services from the City of Tucson; and medical aid supplies from the City of Tampa — bear no relationship to halofenate, a pharmaceutical lipid-regulating agent. The mismatch suggests either miscoding in the state and local procurement system or that halofenate itself does not drive meaningful contracting volume at the state and local level.

Absent recent opportunities that genuinely reflect halofenate procurement, this code presents minimal business development signal for firms in the pharmaceutical or medical supply space pursuing state and local contracts. Firms should monitor whether issuing bodies begin tagging halofenate purchases accurately, or consider whether related pharmaceutical commodity codes better reflect actual buying patterns in their target jurisdictions.